Research Article

Anti-Endocrine Properties of Ganoderma Lucidum on Streptozotocin-Induced Diabetic Rats

Volume: 30 Number: 1 January 11, 2026
  • Macdonald Idu
  • Coker Oluwaseun Oritsema
  • Benjamin Ogunma Gabriel *

Anti-Endocrine Properties of Ganoderma Lucidum on Streptozotocin-Induced Diabetic Rats

Abstract

Ganoderma lucidum has several therapeutic effects, which include; antidiabetic, antihypertensive, antilipidemic, antioxidant, and many more. This study evaluates the anti-endocrine investigation of G. lucidum in streptozotocin-induced diabetic rats. Antidiabetic properties of a modified streptozotocin-induced hyperglycemic model were used. Wistar rats were divided into six groups (n=5). All groups except normal control were induced with streptozotocin (50 mg/kg). Graded doses (30, 50, and 100 mg/kg) of G. lucidum methanol extract and 10 mg/kg glibenclamide were administered for 14 days. Blood glucose was monitored on Days 1, 7, and 14. Blood and tissue samples were analyzed for biochemical and histopathological screening. The anti-endocrine property showed a significant increase in the body weight and HDL (14.99) with an decrease in blood glucose level (day 0= 199.5, 7= 79.00 and 14= 56.00), total cholesterol (73.76), triglycerides (199.30) and LDL level (47.30), ALT (24.48), AST (43.86), ALP (13.36), GGC (0.53), TP (12.72), urea (28.78), creatinine (0.25), sodium (94.69) when compared with the control. A significant decrease in the pancreas and live weight with normal architectural functioning of the organs treated groups when compared with the control. These findings elicited G. lucidum elicited antidiabetic properties.

Keywords

References

  1. [1] Chen D, Wang MW. Development and application of rodent models for type 2 diabetes. Diabetes Obes Metab, 2005; 7: 307–317. https://doi.org/ 10.1111/j.1463-1326.2004.00392.x
  2. [2] Adedokun O, Ogochukwu U, A”{al|Q=O786 11dulkadir N, Adebayo G, Aziba P, Gabriel B. Evaluation of antidiabetic and anti-lipid peroxidation potentials of leaves crude and solvent fractions of Annona muricata Linn (Annonaceae). J Pharmacog Phytochem, 2019; 8(3):3973-3977.
  3. [3] Benjamin OG, Otakhor KO, Owen – Obaseki E. In vitro and in vivo antioxidant evaluation of Guiera senegalensis methanol leaves extract. J Basic Pharmacol Toxicol. 2020; 4(2); 6-12.
  4. [4] Azubike CO, Gabriel BO. Antiglycemic effect of Hunteria umbellate aqueous extract on alloxan induced hyperglycemic albino rats. Ann. Biomed. Sci., 2017; 16(1): 150-155.
  5. [5] Chukwuma OO, Chidozie EA, Ikenna IK, Augusta NC, Jeremiah OS. Anti-diabetic and renal protective effect of the fruit juice of Citrus X Paradisi on alloxan-induced diabetic male albino Wistar rats. Der Pharmacia Lettre. 2016; 8(19):32-38.(http://scholarsresearchlibrary.com/archive.html).
  6. [6] Yuen JW, Gohel MD. The dual roles of Ganoderma antioxidants on urothelial cell DNA under carcinogenic attack. J Ethnopharmacol. 2008; 118:324–30.https://doi.org/10.1016/j.jep.2008.05.003
  7. [7] Saltarelli R, Ceccaroli P, Iotti M. Biochemical characterization and antioxidant activity of mycelium of Ganoderma lucidum from Central Italy. Food Chem. 2009; 116:143–51. https://doi.org/10.1016/j.foodchem.2009.02.023.
  8. [8] Wu Y, Wang D. A new class of natural glycopeptides with sugar moiety-dependent antioxidant activities derived from Ganoderma lucidum fruiting bodies. J Proteome Res. 2009; 8:436–42. https://doi.org/10.1021/pr800554w

Details

Primary Language

English

Subjects

Pharmaceutical Biotechnology

Journal Section

Research Article

Authors

Coker Oluwaseun Oritsema This is me
0009-0005-3848-5642
Benin

Benjamin Ogunma Gabriel * This is me
0000-0002-2513-385X
Benin

Publication Date

January 11, 2026

Submission Date

September 30, 2022

Acceptance Date

September 16, 2024

Published in Issue

Year 2026 Volume: 30 Number: 1

APA
Idu, M., Oritsema, C. O., & Gabriel, B. O. (2026). Anti-Endocrine Properties of Ganoderma Lucidum on Streptozotocin-Induced Diabetic Rats. Journal of Research in Pharmacy, 30(1), 320-329. https://doi.org/10.12991/jrespharm.1845180
AMA
1.Idu M, Oritsema CO, Gabriel BO. Anti-Endocrine Properties of Ganoderma Lucidum on Streptozotocin-Induced Diabetic Rats. J. Res. Pharm. 2026;30(1):320-329. doi:10.12991/jrespharm.1845180
Chicago
Idu, Macdonald, Coker Oluwaseun Oritsema, and Benjamin Ogunma Gabriel. 2026. “Anti-Endocrine Properties of Ganoderma Lucidum on Streptozotocin-Induced Diabetic Rats”. Journal of Research in Pharmacy 30 (1): 320-29. https://doi.org/10.12991/jrespharm.1845180.
EndNote
Idu M, Oritsema CO, Gabriel BO (January 1, 2026) Anti-Endocrine Properties of Ganoderma Lucidum on Streptozotocin-Induced Diabetic Rats. Journal of Research in Pharmacy 30 1 320–329.
IEEE
[1]M. Idu, C. O. Oritsema, and B. O. Gabriel, “Anti-Endocrine Properties of Ganoderma Lucidum on Streptozotocin-Induced Diabetic Rats”, J. Res. Pharm., vol. 30, no. 1, pp. 320–329, Jan. 2026, doi: 10.12991/jrespharm.1845180.
ISNAD
Idu, Macdonald - Oritsema, Coker Oluwaseun - Gabriel, Benjamin Ogunma. “Anti-Endocrine Properties of Ganoderma Lucidum on Streptozotocin-Induced Diabetic Rats”. Journal of Research in Pharmacy 30/1 (January 1, 2026): 320-329. https://doi.org/10.12991/jrespharm.1845180.
JAMA
1.Idu M, Oritsema CO, Gabriel BO. Anti-Endocrine Properties of Ganoderma Lucidum on Streptozotocin-Induced Diabetic Rats. J. Res. Pharm. 2026;30:320–329.
MLA
Idu, Macdonald, et al. “Anti-Endocrine Properties of Ganoderma Lucidum on Streptozotocin-Induced Diabetic Rats”. Journal of Research in Pharmacy, vol. 30, no. 1, Jan. 2026, pp. 320-9, doi:10.12991/jrespharm.1845180.
Vancouver
1.Macdonald Idu, Coker Oluwaseun Oritsema, Benjamin Ogunma Gabriel. Anti-Endocrine Properties of Ganoderma Lucidum on Streptozotocin-Induced Diabetic Rats. J. Res. Pharm. 2026 Jan. 1;30(1):320-9. doi:10.12991/jrespharm.1845180